WORKING GROUPS

CGC working groups were commissioned in August 2015, following a successful roundtable session at the CGC Annual Meeting. Groups were developed to create consensus statements and practice guidelines for the use of genomics in the clinical care of specific tumor types which hopefully will lead to publications that positively impact the appropriate utilization and reimbursement of genomics testing in cancer. Working Group and group leaders are listed below.

CANCER SPECIFIC WORKING GROUPS

FOCUS

Acute Lymphoblastic Leukemia


CNS / Brain Tumors


Multiple myeloma / Plasma Cell Disorders


Myeloid Neoplasms


Renal Cell Carcinoma

Chronic Lymphocytic Leukemia


Melanoma

Breast cancer

GROUP LEADER

Betsy Hirsch (University of Minnesota) and Yassmine Akkari (Legacy Central Laboratory)


Azra Ligon (Harvard Medical School) and Stewart Neill (Emory University)

Min Fang (University of Washington) and Trevor Pugh (University of Toronto)

Xinjie Xu (ARUP Laboratories) and Rashmi Kanagal Shamanna (MD Anderson)

Yajuan Liu (University of Washington)

Patricia Miron (UMassMemorial Medical Center) and Alka Chaubey (Greenwood)

Ravindra Kolhe (Medical College of Georgia)

Katherine Geiersbach (Mayo Clinic)

OTHER WORKING GROUPS

FOCUS

Reporting practices for constitutional genomic testing


GROUP LEADER

Brynn Levy (Columbia University Medical Center) & Catherine Redher (Duke)


The melanoma and breast cancer working groups are currently recruiting additional members. If you have research or clinical experience in these tumor types and are interested in participating, please contact the group leaders Dr. Kolhe (melanoma) and Dr. Geiersbach (Mayo).
The Working Groups will again meet during a roundtable session at the Annual Meeting (Denver, 2017) and lead panel discussions summarizing their groups efforts.  We look forward to the roundtable session and panel presentations being a very meaningful part of the annual meeting!

Comments are closed.